Evidence map›Paper›PMID 42059308›Full record

ArticleHaematologica2026

Idiopathic multicentric Castleman - TAFRO syndrome can mimic sepsis and myeloid neoplasia.

Ole Hudowenz, Jan Vorwerk, Cyrus Khandanpour, Nikolas Von Bubnoff, Wolfram Klapper, Ilske Oschlies, Jonas Ströder, Niklas Gebauer, Philip Muck, Martin Nitschke and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ole HudowenzDepartment of Internal Medicine I, Division of Nephrology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck. ole.hudowenz@uksh.de.
Jan VorwerkDepartment of Hematology and Oncology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck.
Cyrus KhandanpourDepartment of Hematology and Oncology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck, Germany; Department of Hematology and Oncology, Klinikum Oldenburg, Oldenburg, Germany; University Medicine Oldenburg, Carl von Ossietzky University, Oldenburg.
Nikolas Von BubnoffDepartment of Hematology and Oncology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck.
Wolfram KlapperInstitute of Pathology, University Medical Center Schleswig-Holstein - Campus Kiel, Kiel.
Ilske OschliesInstitute of Pathology, University Medical Center Schleswig-Holstein - Campus Kiel, Kiel.
Jonas StröderDepartment of Radiology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck.
Niklas GebauerDepartment of Hematology and Oncology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck.
Philip MuckDepartment of Internal Medicine I, Division of Nephrology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck.
Martin NitschkeDepartment of Internal Medicine I, Division of Nephrology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck.
Tobias GrafDepartment of Internal Medicine II, Intensive Care Unit, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42059308
PMCPMC13628065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.